Live Breaking News & Updates on Marks Anderson|Page 2

Stay updated with breaking news from Marks anderson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA approves first drug to delay onset of Type 1 diabetes

FILE, dmphoto/Getty Images(SILVER SPRING, Md.) For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes. Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio and Sanofi, is administered through intravenous infusion. The injection was shown in clinical trials to delay onset of insulin-dependent Type 1 diabetes for patients with autoantibody markers of early risk by over two years, with hopes for some that it can delay onset even longer. "Today's approval of a first-in-class therapy adds an important new treatment option for certain at-risk patients," said Dr. John Sharretts, director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA's Center for Drug Evaluation and Research. "The drug's potential to delay clinical diagnosis of type 1 diabetes may provide patients with months to years wi ....

United States , John Sharretts , Marks Anderson , Drug Administration On , University Of California San Francisco Diabetes Center , Us Centers For Disease , Division Of Diabetes , Drug Administration , Lipid Disorders , Drug Evaluation , California San Francisco Diabetes , Disease Control ,

FDA Approves a Drug That Can Delay Type 1 Diabetes

FDA Approves a Drug That Can Delay Type 1 Diabetes
nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Kevan Herold , Aaron Kowalski , John Buse , Sonoma Biotherapeutics , Lucienne Chatenoud , Provention Bio , Marks Anderson , Paris Descartes University , University Of California , National Institutes Of Health , Drug Administration , Ortho Pharmaceuticals , University Of North Carolina , North Carolina , National Institutes , New England Journal ,